GUIDANT CORP
10-Q, EX-27, 2000-11-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: GUIDANT CORP, 10-Q, EX-99, 2000-11-14
Next: ICN PHARMACEUTICALS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                              81
<SECURITIES>                                         5
<RECEIVABLES>                                      566
<ALLOWANCES>                                        16
<INVENTORY>                                        221
<CURRENT-ASSETS>                                 1,153
<PP&E>                                             938
<DEPRECIATION>                                     391
<TOTAL-ASSETS>                                   2,491
<CURRENT-LIABILITIES>                              811
<BONDS>                                            431
                                0
                                          0
<COMMON>                                           197
<OTHER-SE>                                         946
<TOTAL-LIABILITY-AND-EQUITY>                     2,491
<SALES>                                          1,900
<TOTAL-REVENUES>                                 1,900
<CGS>                                              452
<TOTAL-COSTS>                                      452
<OTHER-EXPENSES>                                   265
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  43
<INCOME-PRETAX>                                    538
<INCOME-TAX>                                       172
<INCOME-CONTINUING>                                366
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       366
<EPS-BASIC>                                       1.22
<EPS-DILUTED>                                     1.18


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission